1![Iron, α-synuclein and glial contributions in Parkinson’s disease Jun-Xia Xie* Institute of Brain Science and Disease, Qingdao University, Qingdao, 266071, China *Corresponding author E-mail: Ab Iron, α-synuclein and glial contributions in Parkinson’s disease Jun-Xia Xie* Institute of Brain Science and Disease, Qingdao University, Qingdao, 266071, China *Corresponding author E-mail: Ab](https://www.pdfsearch.io/img/bbf1db0d381ed729863f68b6c394dfa0.jpg) | Add to Reading ListSource URL: scnw2018.cns.org.cnLanguage: English - Date: 2018-05-11 03:10:31
|
---|
2![Calcineurin determines toxic versus beneficial responses to α-synuclein Gabriela Caraveoa,b, Pavan K. Aulucka,c,1, Luke Whitesella, Chee Yeun Chunga, Valeriya Barua,b, Eugene V. Mosharovd, Xiaohui Yane, Manu Ben-Johnyf, Calcineurin determines toxic versus beneficial responses to α-synuclein Gabriela Caraveoa,b, Pavan K. Aulucka,c,1, Luke Whitesella, Chee Yeun Chunga, Valeriya Barua,b, Eugene V. Mosharovd, Xiaohui Yane, Manu Ben-Johnyf,](https://www.pdfsearch.io/img/3f2974848d7317f661d90d47ef369e1b.jpg) | Add to Reading ListSource URL: lindquistlab.wi.mit.eduLanguage: English - Date: 2016-05-11 16:38:28
|
---|
3![News Release Ramot at Tel Aviv University Ltd. Announces Licensing Agreement with Dexcel Pharma Technologies Ltd. Under the agreement, a new therapeutic strategy for Parkinson’s disease will be developed using a natur News Release Ramot at Tel Aviv University Ltd. Announces Licensing Agreement with Dexcel Pharma Technologies Ltd. Under the agreement, a new therapeutic strategy for Parkinson’s disease will be developed using a natur](https://www.pdfsearch.io/img/459e6c125fe5890d9b4b85df87c5a121.jpg) | Add to Reading ListSource URL: www.ramot.orgLanguage: English - Date: 2015-07-28 03:31:26
|
---|
4![Aggregated α-synuclein intoxication of primary dopaminergic neurons as an in vitro model of Parkinson diseaseD. Buttigieg ; E. Gras-Lavigne ; M. Ouamer ; R. Steinschneider Aggregated α-synuclein intoxication of primary dopaminergic neurons as an in vitro model of Parkinson diseaseD. Buttigieg ; E. Gras-Lavigne ; M. Ouamer ; R. Steinschneider](https://www.pdfsearch.io/img/1e548924b6e0f19b9aafd68fd69dad64.jpg) | Add to Reading ListSource URL: www.neuronexperts.comLanguage: English - Date: 2015-04-15 11:45:08
|
---|
5![Research Award Laura Vopicelli-Daley, PhD University of Alabama at Birmingham Study Title: LRRK2 in Pathological Synuclein Transmission Research Award Laura Vopicelli-Daley, PhD University of Alabama at Birmingham Study Title: LRRK2 in Pathological Synuclein Transmission](https://www.pdfsearch.io/img/05a799cbb08b731b6fd210eaf059faad.jpg) | Add to Reading ListSource URL: www.apdaparkinson.orgLanguage: English - Date: 2015-01-21 16:49:09
|
---|
6![Research Award Talene Yacoubian, MD, PhD. University of Alabama at Birmingham Project Title: Effects of 14-3-3s on Alpha-synuclein Release and Toxicity Research Award Talene Yacoubian, MD, PhD. University of Alabama at Birmingham Project Title: Effects of 14-3-3s on Alpha-synuclein Release and Toxicity](https://www.pdfsearch.io/img/8bbe275074963bea6f2e8f4f9d8a61cb.jpg) | Add to Reading ListSource URL: www.apdaparkinson.orgLanguage: English - Date: 2015-01-21 16:49:09
|
---|
7![RAPID COMMUNICATION Neuron-to-Neuron Transmission of a-Synuclein Fibrils Through Axonal Transport Eric C. Freundt, PhD,1* Nate Maynard, PhD,2 Eileen K. Clancy, PhD,1 RAPID COMMUNICATION Neuron-to-Neuron Transmission of a-Synuclein Fibrils Through Axonal Transport Eric C. Freundt, PhD,1* Nate Maynard, PhD,2 Eileen K. Clancy, PhD,1](https://www.pdfsearch.io/img/b5286f2c47291e9c48b8821d6cfec6ce.jpg) | Add to Reading ListSource URL: covert.stanford.eduLanguage: English - Date: 2014-05-30 18:39:10
|
---|
8![Background and Justification for The Parkinson’s Progression Markers Initiative Lead Biomarker Candidates Identified Lead PD Biomarker Candidates Alpha-Synuclein Rationale: The central role of alpha-synuclein in the pa Background and Justification for The Parkinson’s Progression Markers Initiative Lead Biomarker Candidates Identified Lead PD Biomarker Candidates Alpha-Synuclein Rationale: The central role of alpha-synuclein in the pa](https://www.pdfsearch.io/img/e8f8b49b57452e387e6aae5dae766fff.jpg) | Add to Reading ListSource URL: www.ppmi-info.orgLanguage: English - Date: 2014-01-31 09:28:08
|
---|
9![124 • The Journal of Neuroscience, January 4, 2012 • 32(1):124 –132 Neurobiology of Disease SIRT1 Protects against !-Synuclein Aggregation by Activating Molecular Chaperones 124 • The Journal of Neuroscience, January 4, 2012 • 32(1):124 –132 Neurobiology of Disease SIRT1 Protects against !-Synuclein Aggregation by Activating Molecular Chaperones](https://www.pdfsearch.io/img/9c1dbb107be472312f8cde484516c016.jpg) | Add to Reading ListSource URL: glennfoundation.orgLanguage: English - Date: 2014-05-17 09:29:08
|
---|
10![Research article Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease Christophe Lo Bianco,1,2 James Shorter,3 Etienne Régulier,2 Hilal Lashuel,2 Takeshi Research article Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease Christophe Lo Bianco,1,2 James Shorter,3 Etienne Régulier,2 Hilal Lashuel,2 Takeshi](https://www.pdfsearch.io/img/6f485e64505e30c0d82faa958aaf70ce.jpg) | Add to Reading ListSource URL: www.med.upenn.eduLanguage: English - Date: 2008-09-02 17:45:30
|
---|